Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AB308 |
Synonyms | |
Therapy Description |
AB308 is a monoclonal antibody that targets and binds to T-cell immunoreceptor with Ig and ITIM domains (TIGIT), potentially resulting in enhanced immune response (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AB308 | AB-308|AB 308 | TIGIT Antibody 19 | AB308 is a monoclonal antibody that targets and binds to T-cell immunoreceptor with Ig and ITIM domains (TIGIT), potentially resulting in enhanced immune response (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|